Robert Eoff
Concepts (281)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
DNA-Directed DNA Polymerase | 29 | 2021 | 96 | 7.470 |
Why?
| DNA | 21 | 2021 | 581 | 4.790 |
Why?
| DNA Replication | 16 | 2021 | 152 | 3.100 |
Why?
| G-Quadruplexes | 7 | 2021 | 81 | 2.580 |
Why?
| Sulfolobus solfataricus | 13 | 2013 | 20 | 2.570 |
Why?
| Enzyme Inhibitors | 6 | 2020 | 446 | 1.830 |
Why?
| Deoxyguanosine | 8 | 2021 | 32 | 1.690 |
Why?
| DNA Damage | 10 | 2019 | 357 | 1.620 |
Why?
| Indoles | 6 | 2019 | 289 | 1.580 |
Why?
| Models, Molecular | 10 | 2021 | 423 | 1.570 |
Why?
| Nucleotidyltransferases | 3 | 2021 | 15 | 1.400 |
Why?
| DNA Polymerase beta | 8 | 2020 | 13 | 1.370 |
Why?
| Kinetics | 25 | 2017 | 692 | 1.310 |
Why?
| Kynurenine | 2 | 2016 | 17 | 1.130 |
Why?
| Archaeal Proteins | 5 | 2009 | 14 | 1.130 |
Why?
| Genomic Instability | 2 | 2016 | 95 | 1.080 |
Why?
| DNA Repair | 7 | 2019 | 203 | 1.080 |
Why?
| Glioblastoma | 4 | 2022 | 99 | 1.040 |
Why?
| DNA, Single-Stranded | 4 | 2017 | 73 | 1.020 |
Why?
| DNA Helicases | 6 | 2012 | 132 | 1.020 |
Why?
| RecQ Helicases | 2 | 2014 | 19 | 0.940 |
Why?
| DNA Adducts | 9 | 2016 | 162 | 0.900 |
Why?
| Antineoplastic Agents | 8 | 2021 | 1300 | 0.810 |
Why?
| Nucleotides | 3 | 2012 | 23 | 0.800 |
Why?
| DNA, Archaeal | 4 | 2012 | 12 | 0.800 |
Why?
| Guanine | 4 | 2013 | 42 | 0.800 |
Why?
| Signal Transduction | 3 | 2017 | 1752 | 0.760 |
Why?
| Exodeoxyribonucleases | 3 | 2014 | 19 | 0.690 |
Why?
| Nucleic Acid Synthesis Inhibitors | 3 | 2013 | 17 | 0.680 |
Why?
| Nuclear Proteins | 3 | 2016 | 253 | 0.660 |
Why?
| Substrate Specificity | 10 | 2015 | 209 | 0.640 |
Why?
| Nucleic Acid Conformation | 5 | 2012 | 99 | 0.630 |
Why?
| Escherichia coli Proteins | 2 | 2017 | 100 | 0.630 |
Why?
| Magnesium | 3 | 2014 | 42 | 0.630 |
Why?
| Small Molecule Libraries | 3 | 2018 | 72 | 0.620 |
Why?
| Thiobarbiturates | 2 | 2018 | 23 | 0.620 |
Why?
| Werner Syndrome | 1 | 2017 | 14 | 0.600 |
Why?
| Mitochondrial Proteins | 1 | 2017 | 121 | 0.570 |
Why?
| DNA Polymerase II | 2 | 2015 | 10 | 0.560 |
Why?
| Crystallography, X-Ray | 9 | 2012 | 178 | 0.550 |
Why?
| Base Pairing | 5 | 2010 | 28 | 0.550 |
Why?
| DNA, Mitochondrial | 1 | 2017 | 186 | 0.540 |
Why?
| Glioma | 1 | 2016 | 79 | 0.540 |
Why?
| Manganese | 2 | 2014 | 24 | 0.540 |
Why?
| Biocatalysis | 2 | 2014 | 20 | 0.530 |
Why?
| Cisplatin | 1 | 2018 | 351 | 0.530 |
Why?
| Humans | 42 | 2022 | 54391 | 0.530 |
Why?
| Deoxyribonucleotides | 2 | 2012 | 4 | 0.520 |
Why?
| DNA Primase | 1 | 2014 | 8 | 0.510 |
Why?
| Molecular Docking Simulation | 6 | 2018 | 83 | 0.490 |
Why?
| DNA-Binding Proteins | 1 | 2017 | 462 | 0.490 |
Why?
| Viral Proteins | 2 | 2006 | 158 | 0.480 |
Why?
| Lipoxygenase Inhibitors | 1 | 2013 | 6 | 0.460 |
Why?
| Leukotrienes | 1 | 2013 | 10 | 0.460 |
Why?
| Promoter Regions, Genetic | 1 | 2015 | 520 | 0.450 |
Why?
| Malondialdehyde | 2 | 2010 | 63 | 0.450 |
Why?
| Protein Structure, Tertiary | 8 | 2015 | 289 | 0.440 |
Why?
| Neoplasms | 3 | 2018 | 1322 | 0.440 |
Why?
| Stilbenes | 4 | 2018 | 65 | 0.430 |
Why?
| Up-Regulation | 1 | 2014 | 509 | 0.430 |
Why?
| Structure-Activity Relationship | 9 | 2020 | 423 | 0.420 |
Why?
| Catalysis | 8 | 2012 | 98 | 0.420 |
Why?
| Cell Line, Tumor | 10 | 2022 | 1551 | 0.420 |
Why?
| Adenosine Triphosphate | 2 | 2012 | 242 | 0.420 |
Why?
| Protein Binding | 8 | 2021 | 736 | 0.400 |
Why?
| Nucleosides | 1 | 2010 | 5 | 0.390 |
Why?
| DNA Primers | 5 | 2015 | 225 | 0.390 |
Why?
| Binding Sites | 6 | 2017 | 440 | 0.380 |
Why?
| Molecular Structure | 6 | 2021 | 319 | 0.360 |
Why?
| Base Sequence | 9 | 2014 | 719 | 0.350 |
Why?
| Inhibitory Concentration 50 | 3 | 2020 | 80 | 0.340 |
Why?
| Brain Neoplasms | 2 | 2022 | 285 | 0.320 |
Why?
| Catalytic Domain | 4 | 2014 | 61 | 0.320 |
Why?
| Models, Chemical | 2 | 2008 | 65 | 0.310 |
Why?
| Organoids | 3 | 2022 | 41 | 0.300 |
Why?
| Cytosine | 1 | 2006 | 29 | 0.290 |
Why?
| Bacteriophage T4 | 2 | 2009 | 23 | 0.280 |
Why?
| Drug Screening Assays, Antitumor | 7 | 2021 | 142 | 0.270 |
Why?
| Pyrimidines | 3 | 2021 | 196 | 0.270 |
Why?
| DNA, Viral | 2 | 2009 | 143 | 0.270 |
Why?
| Oligonucleotides | 2 | 2021 | 76 | 0.260 |
Why?
| Cell Line | 4 | 2021 | 1152 | 0.260 |
Why?
| Drug Discovery | 2 | 2021 | 90 | 0.240 |
Why?
| Templates, Genetic | 3 | 2014 | 17 | 0.240 |
Why?
| Base Pair Mismatch | 3 | 2015 | 24 | 0.230 |
Why?
| Mutation | 3 | 2021 | 1504 | 0.220 |
Why?
| Induced Pluripotent Stem Cells | 1 | 2022 | 44 | 0.210 |
Why?
| STAT2 Transcription Factor | 1 | 2021 | 7 | 0.210 |
Why?
| Inositol | 1 | 2021 | 16 | 0.210 |
Why?
| STAT1 Transcription Factor | 1 | 2021 | 27 | 0.210 |
Why?
| Li-Fraumeni Syndrome | 1 | 2021 | 13 | 0.210 |
Why?
| AMP-Activated Protein Kinases | 1 | 2021 | 29 | 0.200 |
Why?
| Mutation, Missense | 2 | 2016 | 117 | 0.200 |
Why?
| Mitochondrial Dynamics | 1 | 2021 | 22 | 0.200 |
Why?
| Biological Specimen Banks | 1 | 2021 | 21 | 0.200 |
Why?
| Pyrans | 1 | 2021 | 27 | 0.200 |
Why?
| Nucleotide Motifs | 1 | 2021 | 29 | 0.200 |
Why?
| Molecular Sequence Data | 4 | 2013 | 980 | 0.200 |
Why?
| Benzopyrans | 1 | 2020 | 12 | 0.190 |
Why?
| Genes, myc | 1 | 2021 | 47 | 0.190 |
Why?
| Antibiotics, Antineoplastic | 1 | 2021 | 85 | 0.190 |
Why?
| Germ-Line Mutation | 2 | 2021 | 68 | 0.190 |
Why?
| Neoplastic Stem Cells | 1 | 2021 | 104 | 0.180 |
Why?
| Fluorescence Polarization | 2 | 2016 | 17 | 0.180 |
Why?
| Cytoplasmic Dyneins | 1 | 2019 | 3 | 0.180 |
Why?
| Alkylation | 1 | 2019 | 10 | 0.180 |
Why?
| HIV Reverse Transcriptase | 2 | 2010 | 3 | 0.170 |
Why?
| Cell Proliferation | 5 | 2018 | 1097 | 0.170 |
Why?
| DNA Breaks, Double-Stranded | 1 | 2019 | 78 | 0.170 |
Why?
| Amino Acid Substitution | 4 | 2014 | 105 | 0.170 |
Why?
| Tubulin Modulators | 2 | 2016 | 40 | 0.160 |
Why?
| Cytochrome P-450 CYP1A2 | 2 | 2008 | 46 | 0.160 |
Why?
| Recombinant Proteins | 3 | 2014 | 570 | 0.160 |
Why?
| HeLa Cells | 2 | 2016 | 291 | 0.150 |
Why?
| Breast Neoplasms | 2 | 2021 | 1249 | 0.150 |
Why?
| Stress, Physiological | 2 | 2021 | 194 | 0.150 |
Why?
| Protein Multimerization | 1 | 2017 | 54 | 0.150 |
Why?
| Mass Spectrometry | 2 | 2009 | 313 | 0.150 |
Why?
| Naphthalenes | 1 | 2018 | 126 | 0.150 |
Why?
| Receptors, Opioid, delta | 1 | 2016 | 25 | 0.140 |
Why?
| Molecular Targeted Therapy | 1 | 2017 | 128 | 0.140 |
Why?
| Protein Conformation | 4 | 2009 | 226 | 0.140 |
Why?
| Cytoplasmic Granules | 1 | 2016 | 24 | 0.140 |
Why?
| Receptors, Opioid, mu | 1 | 2016 | 47 | 0.140 |
Why?
| Morphine Derivatives | 1 | 2016 | 30 | 0.140 |
Why?
| Dioxanes | 1 | 2016 | 10 | 0.140 |
Why?
| Acetonitriles | 1 | 2016 | 7 | 0.140 |
Why?
| Animals | 8 | 2021 | 14409 | 0.140 |
Why?
| Calcium | 2 | 2010 | 434 | 0.140 |
Why?
| Morphine | 1 | 2016 | 95 | 0.140 |
Why?
| Cytoplasm | 1 | 2016 | 109 | 0.140 |
Why?
| Barbiturates | 1 | 2015 | 16 | 0.140 |
Why?
| Peptide Nucleic Acids | 2 | 2006 | 17 | 0.130 |
Why?
| Analgesics | 1 | 2016 | 107 | 0.130 |
Why?
| Benzodioxoles | 1 | 2016 | 56 | 0.130 |
Why?
| Tumor Cells, Cultured | 1 | 2015 | 477 | 0.130 |
Why?
| Tubulin | 1 | 2014 | 28 | 0.130 |
Why?
| Heterocyclic Compounds | 1 | 2014 | 30 | 0.130 |
Why?
| Triazoles | 1 | 2015 | 119 | 0.130 |
Why?
| Deoxycytidine Monophosphate | 1 | 2013 | 5 | 0.120 |
Why?
| Protein Biosynthesis | 1 | 2016 | 273 | 0.120 |
Why?
| Deoxyadenosines | 1 | 2013 | 5 | 0.120 |
Why?
| Hydrogen Bonding | 3 | 2009 | 45 | 0.120 |
Why?
| Deoxycytosine Nucleotides | 2 | 2014 | 3 | 0.120 |
Why?
| Molecular Conformation | 2 | 2010 | 73 | 0.120 |
Why?
| Dose-Response Relationship, Drug | 5 | 2018 | 1476 | 0.110 |
Why?
| DNA Repair Enzymes | 1 | 2013 | 50 | 0.110 |
Why?
| Deoxyadenine Nucleotides | 1 | 2012 | 4 | 0.110 |
Why?
| Carbohydrate Conformation | 1 | 2012 | 8 | 0.110 |
Why?
| RNA, Messenger | 1 | 2016 | 1203 | 0.110 |
Why?
| Nucleic Acids | 1 | 2012 | 13 | 0.110 |
Why?
| Gene Expression Regulation, Neoplastic | 2 | 2021 | 868 | 0.110 |
Why?
| Diphosphates | 2 | 2014 | 7 | 0.100 |
Why?
| Amino Acid Sequence | 2 | 2013 | 767 | 0.100 |
Why?
| Oxidative Stress | 1 | 2016 | 958 | 0.100 |
Why?
| HIV-1 | 1 | 2010 | 72 | 0.090 |
Why?
| Macromolecular Substances | 1 | 2009 | 47 | 0.090 |
Why?
| Magnesium Chloride | 1 | 2009 | 1 | 0.090 |
Why?
| African Swine Fever Virus | 1 | 2009 | 1 | 0.090 |
Why?
| Purine Nucleotides | 1 | 2009 | 1 | 0.090 |
Why?
| Deuterium | 1 | 2009 | 41 | 0.090 |
Why?
| Disulfides | 1 | 2009 | 15 | 0.090 |
Why?
| Uridine | 1 | 2009 | 6 | 0.090 |
Why?
| Sulfhydryl Compounds | 1 | 2009 | 19 | 0.090 |
Why?
| Protein Structure, Secondary | 1 | 2009 | 99 | 0.090 |
Why?
| Cyanides | 1 | 2008 | 4 | 0.080 |
Why?
| Phenyl Ethers | 1 | 2008 | 5 | 0.080 |
Why?
| Mutagenesis, Site-Directed | 3 | 2014 | 117 | 0.080 |
Why?
| Pyrenes | 1 | 2008 | 5 | 0.080 |
Why?
| Escherichia coli | 2 | 2009 | 250 | 0.080 |
Why?
| Toluene | 1 | 2007 | 9 | 0.080 |
Why?
| Peptides | 1 | 2009 | 276 | 0.080 |
Why?
| Bacterial Proteins | 2 | 2011 | 456 | 0.080 |
Why?
| DNA, Bacterial | 1 | 2007 | 172 | 0.070 |
Why?
| Nucleic Acid Denaturation | 1 | 2006 | 14 | 0.070 |
Why?
| Biopolymers | 1 | 2006 | 14 | 0.070 |
Why?
| Least-Squares Analysis | 1 | 2006 | 45 | 0.070 |
Why?
| Nitriles | 2 | 2021 | 69 | 0.070 |
Why?
| Stereoisomerism | 2 | 2016 | 106 | 0.070 |
Why?
| Static Electricity | 1 | 2005 | 20 | 0.070 |
Why?
| Enzyme Stability | 1 | 2005 | 27 | 0.070 |
Why?
| Mice, Knockout | 2 | 2021 | 927 | 0.060 |
Why?
| Organophosphorus Compounds | 1 | 2005 | 17 | 0.060 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 124 | 0.060 |
Why?
| Phosphorylation | 2 | 2021 | 613 | 0.060 |
Why?
| Oxygen | 1 | 2008 | 361 | 0.060 |
Why?
| Hot Temperature | 1 | 2005 | 199 | 0.060 |
Why?
| DNA Polymerase I | 2 | 2013 | 8 | 0.060 |
Why?
| Monensin | 1 | 2022 | 14 | 0.050 |
Why?
| Mice, Inbred C57BL | 2 | 2021 | 2001 | 0.050 |
Why?
| Janus Kinase 1 | 1 | 2021 | 20 | 0.050 |
Why?
| Mutagens | 2 | 2013 | 81 | 0.050 |
Why?
| Janus Kinase 2 | 1 | 2021 | 31 | 0.050 |
Why?
| Female | 4 | 2021 | 28471 | 0.050 |
Why?
| Spheroids, Cellular | 1 | 2021 | 26 | 0.050 |
Why?
| Phosphoric Monoester Hydrolases | 1 | 2021 | 24 | 0.050 |
Why?
| Tissue Culture Techniques | 1 | 2021 | 46 | 0.050 |
Why?
| MCF-7 Cells | 1 | 2021 | 79 | 0.050 |
Why?
| Phenol | 1 | 2020 | 10 | 0.050 |
Why?
| Chemistry Techniques, Synthetic | 1 | 2020 | 20 | 0.050 |
Why?
| Tumor Microenvironment | 1 | 2022 | 210 | 0.050 |
Why?
| Pyrazoles | 1 | 2021 | 110 | 0.050 |
Why?
| Chromatography, Liquid | 1 | 2021 | 243 | 0.050 |
Why?
| Sequence Homology, Amino Acid | 2 | 2013 | 180 | 0.050 |
Why?
| Neoplasm Invasiveness | 1 | 2021 | 294 | 0.050 |
Why?
| Tandem Mass Spectrometry | 1 | 2021 | 248 | 0.050 |
Why?
| Cell Division | 1 | 2021 | 330 | 0.050 |
Why?
| Cell Movement | 1 | 2021 | 271 | 0.050 |
Why?
| Drug Design | 1 | 2020 | 133 | 0.050 |
Why?
| Temperature | 1 | 2020 | 177 | 0.050 |
Why?
| Vitamin E | 1 | 2020 | 107 | 0.040 |
Why?
| BRCA1 Protein | 1 | 2019 | 40 | 0.040 |
Why?
| Transcriptome | 1 | 2021 | 346 | 0.040 |
Why?
| Rats | 2 | 2016 | 3419 | 0.040 |
Why?
| Cations, Divalent | 2 | 2010 | 8 | 0.040 |
Why?
| Radiation, Ionizing | 1 | 2019 | 120 | 0.040 |
Why?
| Chromatin | 1 | 2019 | 156 | 0.040 |
Why?
| Male | 4 | 2021 | 27347 | 0.040 |
Why?
| Ligands | 2 | 2008 | 229 | 0.040 |
Why?
| Mitochondria | 1 | 2021 | 490 | 0.040 |
Why?
| Oxidation-Reduction | 2 | 2009 | 383 | 0.040 |
Why?
| Rabbits | 2 | 2008 | 425 | 0.040 |
Why?
| Mice | 2 | 2021 | 6428 | 0.040 |
Why?
| Cricetulus | 1 | 2016 | 102 | 0.040 |
Why?
| CHO Cells | 1 | 2016 | 123 | 0.040 |
Why?
| Receptors, Opioid, kappa | 1 | 2016 | 40 | 0.040 |
Why?
| Drug Tolerance | 1 | 2016 | 60 | 0.040 |
Why?
| Cricetinae | 1 | 2016 | 209 | 0.040 |
Why?
| Adult | 2 | 2022 | 14207 | 0.030 |
Why?
| Diabetes Mellitus, Experimental | 1 | 2016 | 140 | 0.030 |
Why?
| Guanosine | 1 | 2014 | 6 | 0.030 |
Why?
| Models, Biological | 2 | 2009 | 825 | 0.030 |
Why?
| Mutagenicity Tests | 1 | 2013 | 56 | 0.030 |
Why?
| DNA End-Joining Repair | 1 | 2013 | 14 | 0.030 |
Why?
| DNA Mismatch Repair | 1 | 2013 | 17 | 0.030 |
Why?
| Mice, 129 Strain | 1 | 2013 | 49 | 0.030 |
Why?
| Mice, Mutant Strains | 1 | 2013 | 84 | 0.030 |
Why?
| Mutant Proteins | 1 | 2013 | 41 | 0.030 |
Why?
| Pain | 1 | 2016 | 405 | 0.030 |
Why?
| Meiosis | 1 | 2013 | 70 | 0.030 |
Why?
| Acrolein | 1 | 2012 | 3 | 0.030 |
Why?
| Terpenes | 1 | 2012 | 16 | 0.030 |
Why?
| Biphenyl Compounds | 1 | 2012 | 30 | 0.030 |
Why?
| Ultraviolet Rays | 1 | 2012 | 56 | 0.030 |
Why?
| Cell Line, Transformed | 1 | 2012 | 88 | 0.030 |
Why?
| Tetrazoles | 1 | 2012 | 43 | 0.030 |
Why?
| Rats, Sprague-Dawley | 1 | 2016 | 1664 | 0.030 |
Why?
| Benzimidazoles | 1 | 2012 | 54 | 0.030 |
Why?
| Drug Evaluation, Preclinical | 1 | 2012 | 158 | 0.030 |
Why?
| DNA Polymerase III | 1 | 2011 | 6 | 0.030 |
Why?
| Young Adult | 1 | 2021 | 4318 | 0.030 |
Why?
| Analgesics, Opioid | 1 | 2016 | 500 | 0.030 |
Why?
| Peroxides | 1 | 2010 | 5 | 0.020 |
Why?
| Structural Homology, Protein | 1 | 2010 | 9 | 0.020 |
Why?
| Cell Survival | 1 | 2012 | 657 | 0.020 |
Why?
| Adolescent | 1 | 2021 | 6900 | 0.020 |
Why?
| Sulfolobus | 1 | 2009 | 1 | 0.020 |
Why?
| X-Ray Diffraction | 1 | 2009 | 21 | 0.020 |
Why?
| Guanosine Triphosphate | 1 | 2009 | 23 | 0.020 |
Why?
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2009 | 34 | 0.020 |
Why?
| Apoptosis | 1 | 2015 | 1302 | 0.020 |
Why?
| Polynucleotide 5'-Hydroxyl-Kinase | 1 | 2009 | 1 | 0.020 |
Why?
| Purine Nucleosides | 1 | 2009 | 3 | 0.020 |
Why?
| Uracil-DNA Glycosidase | 1 | 2009 | 6 | 0.020 |
Why?
| Purines | 1 | 2009 | 45 | 0.020 |
Why?
| Child | 1 | 2021 | 7368 | 0.020 |
Why?
| Enzyme Activation | 1 | 2009 | 328 | 0.020 |
Why?
| Ferrous Compounds | 1 | 2008 | 11 | 0.020 |
Why?
| Ferric Compounds | 1 | 2008 | 14 | 0.020 |
Why?
| Fungal Proteins | 1 | 2009 | 133 | 0.020 |
Why?
| Virus Replication | 1 | 2009 | 143 | 0.020 |
Why?
| Thymine | 1 | 2007 | 11 | 0.020 |
Why?
| Spectrometry, Fluorescence | 1 | 2008 | 53 | 0.020 |
Why?
| RNA | 1 | 2009 | 202 | 0.020 |
Why?
| Hydrophobic and Hydrophilic Interactions | 1 | 2007 | 42 | 0.020 |
Why?
| Magnetic Resonance Spectroscopy | 1 | 2008 | 255 | 0.020 |
Why?
| Exodeoxyribonuclease V | 1 | 2006 | 2 | 0.020 |
Why?
| Microsomes, Liver | 1 | 2008 | 214 | 0.020 |
Why?
| Models, Genetic | 1 | 2006 | 209 | 0.020 |
Why?
| Models, Statistical | 1 | 2006 | 259 | 0.020 |
Why?
| Time Factors | 1 | 2006 | 3210 | 0.010 |
Why?
|
|
Eoff's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|